Preview

Antibiot Khimioter = Antibiotics and Chemotherapy

Advanced search

Community-Acquired Pneumonia of Bacterial Etiology and the Spectrum of Pathogen Sensitivity to Antibiotics in Corona-Positive and Corona-Negative Patients in Rostov-on-Don

https://doi.org/10.37489/0235-2990-2021-66-1-2-26-32

Abstract

Relevance. In the context of the ongoing pandemic of coronavirus infection, the course of viral pneumonia is often complicated by the addition of bacterial microflora due to a decrease in the body's immune status. The causative agents of such a co-infection can exhibit multiple drug resistance, which significantly reduces the effectiveness of etiotropic therapy. In this regard, it seems expedient to provide microbiological support to patients in order to select the most optimal treatment regimens. 

Aim. To study the composition of bacterial pathogens’ species, that cause community-acquired pneumonia (CAP) in corona-positive (COVID-19+) and corona-negative (COVID-19–) patients and to determine the spectrum of their sensitivity/resistance to antibacterial drugs. 

Material and methods. The species composition of microorganisms in sputum samples from 723 patients with CAP, who were admitted from the healthcare facility in Rostov-on-Don in August and December 2020 were studied. The isolated cultures were identified using bacteriological and mass spectrometric methods. The sensitivity of bacteria to antibiotics was determined by the disk diffusion method. 

Results. It was shown that in August pneumococci and  staphylococci prevailed in the spectrum of CAP pathogens, while in December the percentage of excretions of Acinetobacter spp. and S. haemolyticus increased. Various types of p. Candida yeast were found with a high degree of isolation, COVID-19 + patients showed a tendency towards greater contamination (I104 mcl/ml). Some pathogens (A.baumannii, S.haemolyticus, P.aeruginosa, S.maltophilia) are characterized by polydrug resistance, and some strains of these species are pan-resistant to all groups of antibiotics. 

Conclusion. The data obtained demonstrate that severe forms of community-acquired pneumonia can be caused by viral-bacterial and viral-bacterial-yeast combinations of pathogens, including bacteria with a narrow spectrum of sensitivity to antibacterial drugs. 

About the Authors

N. V. Pavlovich
Rostov-on-Don Plague Control Research Institute
Russian Federation

Natalia V. Pavlovich — D.Sc. in medicine, Chief Researcher

 Rostov-on-Don



М. V. Tsymbalistova
Rostov-on-Don Plague Control Research Institute
Russian Federation

Marina V. Tsymbalistova — Ph.D. in medicine, Senior Researcher

 Rostov-on-Don



N. V. Aronova
Rostov-on-Don Plague Control Research Institute
Russian Federation

Nadezhda V. Aronova— Ph.D. in biology, Senior Researcher

 Rostov-on-Don



A. S. Anisimova
Rostov-on-Don Plague Control Research Institute
Russian Federation

Anastasia S. Anisimova — Junior Researcher

 Rostov-on-Don



S. О. Vodopyanov
Rostov-on-Don Plague Control Research Institute
Russian Federation

Sergey O. Vodopyanov — D.Sc. in medicine, Chief Researcher

 Rostov-on-Don

 

 



А. S. Vodopyanov
Rostov-on-Don Plague Control Research Institute
Russian Federation

Alexey S. Vodopyanov — Ph.D. in medicine, Senior Researcher

 Rostov-on-Don



E. N. Gudueva
Rostov-on-Don Plague Control Research Institute
Russian Federation

Elena N. Gudueva — Junior Researcher

 Rostov-on-Don



М. М. Sagakyants
Rostov-on-Don Plague Control Research Institute
Russian Federation

Margarita M. Sagakyants — Researcher

 Rostov-on-Don



Е. V. Kovalev
Rospotrebnadzor Administration for the Rostov Region
Russian Federation

Evgeny V. Kovalev — Head

Rostov-on-Don



A. К. Noskov
Rostov-on-Don Plague Control Research Institute
Russian Federation

Alexsey K. Noskov — Director

Rostov-on-Don



References

1. Zaitsev A.A., Sinopal'nikov A.I. «Trudnaya» pnevmoniya. Moscow: 2020. (in Russian)

2. Golubkova A.A., Platonova T.A., Sklyar M.S., Vorob'ev A.V., Makarochkina N.G., Karbovnichaya E.A. et al. Strukturnyi analiz zabolevaemosti COVID-19 personala krupnogo mnogoprofil'nogo meditsinskogo tsentra. Sbornik tezisov VIII Kongressa s mezhdunarodnym uchastiem «Kontrol' i profilaktika infektsii, svyazannykh s okazaniem meditsinskoi pomoshchi (ISMP-2020)»; Noyabr' 25–27, 2020; Moscow. Pod red. akademika RAN V.G.Akimkina. Moscow: FBUN TsNII Epidemiologii Rospotrebnadzora, 2020; 29–30. (in Russian)

3. Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID 19: immunity, inflammation and intervention. Nat Rev Immunol. 2020; 20: 363–374. doi: 10.1038/s41577-020-0311-8

4. Chen N., Zhou M., Dong X., Qu J, Gong F., Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneu monia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507–513. doi: 10.1016/S0140-6736(20)30211-7

5. Arastehfar A., Carvalho A., van de Veerdonk F.L., Jerey D. Jenks, Koehler P., Krause R. et al. COVID-19 Associated Pulmonary Aspergillosis (CAPA) — from immunology to treatment. J Fungi. 2020; 6 (2): 91. doi: 10.3390/jof6020091

6. Chatterjee M., Anju C.P., Biswas L., Kumar V.A., Mohan C.G., Biswas R. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol. 2016; 306 (1): 48–58. doi: 10.1016/j.ijmm.2015.11.004

7. Bondarenko A.P., Shmylenko V.A., Trotsenko O.E., Kotova V.O., Butakova L.V., Bazykina E.A. Characteristics of Bacterial Microflora Isolated from Sputum of Patients with Pneumonia Registered in Khabarovsk City and Khabarovsk Territory in the Initial Period of COVID-19 Pandemic in May–June, 2020. Problems of Particularly Dangerous Infections. 2020; 3: 43–49. doi: 10.21055/0370-1069-2020-3-43-49 (in Russian)

8. Popova A.Y., Ezhlova E.B., Demina Y.V., Noskov A.K., Kovalev E.V., Chemisova O.S. et al. Features of Etiology of Community-Acquired Pneumonia Associated with COVID 19. Problems of Particularly Dangerous Infections. 2020; 4: 99–105. doi: 10.21055/0370-1069-2020-4-99-105 (in Russian)

9. Aitken S.L., Clancy C.J. Guidance on the treatment of antimicrobial resistant gram-negative infections. Contagion. 2020; 5 (6): 22–23.

10. Lee C-R., Cho H., Jeong B.C., Lee C.H. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health. 2013; 10 (9): 4274–4305. doi: 10.3390/ijerph10094274

11. Zaitsev A.A. Vnebol- 'nichnaya pnevmoniya: vozmozhnosti diagnostiki, lecheniya i vaktsinoprofilaktiki v usloviyakh pandemii COVID-19. Prakticheskaya Pul'monologiya. 2020; 1: 14–21. (in Russian)

12. Sattar S.B.A., Sharma S. Bacterial Pneumonia. 2020. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513321/

13. Laboratornaya diagnos tika vnebol'nichnykh pnevmonii: Metodicheskie ukazaniya MUK  4.2.3115-13. Moscow: 2013. (in Russian)

14. Laboratornaya diagnostika vnebol'nichnoi pnevmonii pnevmokokkovoi etiologii: Metodicheskie rekomendatsii MR 4.2.0114-16. Moscow: 2016. (in Russian)

15. Klinicheskie rekomendatsii MZ RF. Kistoznyi fibroz (mukovistsidoz): mikrobiologicheskaya diagnostika khronicheskoi respiratornoi infektsii, 2018. (in Russian)

16. Nozokomial'naya pnevmoniya u vzroslykh: Rossiiskie natsional'nye rekomendatsii. Pod red. B.R. Gel'fanda; otv. red. D.N. Protsenko, B.Z. Belotserkovskii. 2 izd., pererab. i dop. Moscow: OOO «Izdatel'stvo «Meditsinskoe informatsionnoe agentstvo», 2016. (in Russian)

17. Moroz A.F., Snegireva A.E. Griby roda Candida (Metody vydeleniya, identifikatsii na vidovom urovne i opredelenie chuvstvitel'nosti k protivogribkovym preparatam). Metodicheskie rekomendatsii. Moscow: NIIEM im. N. F. Gamalei RAMN, 2009. (in Russian)

18. Opredelenie chuvstvitel'nosti mikroorganizmov k antibakterial'nym preparatam: Metodicheskie ukazaniya MUK 4.2.1890-04. Moscow: 2004. (in Russian)


Review

For citations:


Pavlovich N.V., Tsymbalistova М.V., Aronova N.V., Anisimova A.S., Vodopyanov S.О., Vodopyanov А.S., Gudueva E.N., Sagakyants М.М., Kovalev Е.V., Noskov A.К. Community-Acquired Pneumonia of Bacterial Etiology and the Spectrum of Pathogen Sensitivity to Antibiotics in Corona-Positive and Corona-Negative Patients in Rostov-on-Don. Antibiot Khimioter = Antibiotics and Chemotherapy. 2021;66(1-2):26-32. (In Russ.) https://doi.org/10.37489/0235-2990-2021-66-1-2-26-32

Views: 1069


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0235-2990 (Print)